16 min listen
July 14, 2023
FromThe Top Line
ratings:
Length:
38 minutes
Released:
Jul 14, 2023
Format:
Podcast episode
Description
In this episode of "The Top Line," we talk with Dr Reanne Moore, an associate professor of psychiatry at the University of California San Diego, about the state of digital phenotyping. We also cover the vaccine patent lawsuits, the smallest insulin pump, and the rest of the week's headlines.
To learn more about the topics in this episode:
Nominations for Fierce Biotech's 2023 Fierce 15 close Friday—three more days to submit
The Future of Biotech
ADC puts Zynlonta study on hold after 7 patient deaths, 5 other severe adverse events
Tandem crosses FDA finish line with nod for miniaturized insulin pump
Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech: report
Novartis retreats from TIGIT, handing $300M candidate back to BeiGene
Illumina receives record €432M fine from EU for false start on Grail deal
"The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.See omnystudio.com/listener for privacy information.
To learn more about the topics in this episode:
Nominations for Fierce Biotech's 2023 Fierce 15 close Friday—three more days to submit
The Future of Biotech
ADC puts Zynlonta study on hold after 7 patient deaths, 5 other severe adverse events
Tandem crosses FDA finish line with nod for miniaturized insulin pump
Moderna mounts 2 new patent lawsuits against mRNA rivals Pfizer, BioNTech: report
Novartis retreats from TIGIT, handing $300M candidate back to BeiGene
Illumina receives record €432M fine from EU for false start on Grail deal
"The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.See omnystudio.com/listener for privacy information.
Released:
Jul 14, 2023
Format:
Podcast episode
Titles in the series (99)
September 23rd, 2022 by The Top Line